Bile secretory function in the obese Zucker rat: Evidence of cholestasis and altered canalicular transport function

Gut

Volumn 53, Issue 12, 2004, Pages 1837-1843

  Pizarro, M ^a   Balasubramaniyan, N ^b   Solis N ^a   Solar, A ^a   Duarte, I ^a   Miquel, J F ^a   Suchy, F J ^b   Trauner, M ^c   Accatino, L ^a   Ananthanarayanan, M ^b   Arrese, M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE SALT; CARRIER PROTEIN; DRUG; EMBREL; ETANERCEPT; GLUTATHIONE; INSULIN SENSITIZING AGENT; LEPTIN; LIPID; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; POLYPEPTIDE; PROTEIN; PROTEIN BSEP; ROSIGLITAZONE; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE FLOW; BILE SECRETION; BODY WEIGHT; CHOLESTASIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; EXPERIMENTAL MODEL; FATTY LIVER; GLUTATHIONE METABOLISM; HEPATOBILIARY SYSTEM; HYPERLIPIDEMIA; INSULIN RESISTANCE; INTRAHEPATIC BILE DUCT; LEPTIN RESISTANCE; LIPID BILE LEVEL; LIPID TRANSPORT; LIVER INJURY; MALE; MOLECULAR BIOLOGY; NONHUMAN; NORTHERN BLOTTING; OBESITY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; TRANSPORT KINETICS; WESTERN BLOTTING;

ANIMALS; BILE; BILE CANALICULI; BIOLOGICAL TRANSPORT, ACTIVE; BODY WEIGHT; CHOLESTASIS; DOWN-REGULATION; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OBESITY; ORGAN SIZE; RATS; RATS, ZUCKER; RNA, MESSENGER;

EID: 9344262376     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.037689     Document Type: Article

References (52)

1. Alba LM, Lindor K. Non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2003;17:977-86.
2. Angulo P, Lindor KD, Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002;17(suppl):S186-90.
3. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-25.
4. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-5.
5. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:663-78.
6. Friedman SI. Liver fibrosis-from bench to bedside. J Hepatol 2003;38(suppl 1):S38-53.
7. Yang SQ, Lin HZ, Lane MD, et al. Obesity increases sensitivity to endotoxin liver injury: implications for the pothogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997;94:2557-62.
8. Haines NW, Baker AL, Boyer JL, et al. Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: a prospective study. Hepatology 1981;1:161-7.
9. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002;73:325-30.
10. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001;21:89-104.
11. Koneru B, Reddy MC, de la Torre AN, et al. Studies of hepatic warm ischemia in the obese Zucker rat. Transplantation 1995;59:942-6.
12. Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 2002;282:G1-5.
13. Harrison SA, Diehl AM. Fat and the liver - a molecular overview. Semin Gastrointest Dis 2002;13:3-16.
14. Li Z, Lin H, Yang S, et al. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 2002;123:1304-10.
15. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation: current clinical and experimental perspectives. Transplantation 2002;73:325-30.
16. Arrese M, Ananthananarayanan M, Suchy FJ. Hepatobiliary transport: molecular mechanisms of development and cholestasis. Pediatr Res 1998;44:141-7.
17. Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis. Trends Mol Med 2003;9:558-64.
18. Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003;83:633-71.
19. Elferink RO, Groen AK. Genetic defects in hepatobiliary transport. Biochim Biophys Acta 2002;1586:129-45.
20. Talalay P. Enzymatic analysis of steroid hormones. Methods Biochem Anal 1960;8:119-43.
21. Turley SA, Dietschy JM. Re-evaluation of the 3-alpha-hydroxystereiod dehydrogenase assay for total bile acids in bile. J Lipid Res 1978;19:924-8.
22. Baginski ES, Foa PP, Zak B. Microdetermination of inorganic phosphate, phospholipids and total phosphate in biological materials. Clin Chem 1967;13:326-32.
23. Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
24. Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 1985;113:548-55.
25. Seeling G, Meister A. Cystamine-sepharose: A probe for the active site of γ-glutamylcysteine synthetase. J Biol Chem 1982;257:5092-6.
26. +/taurocholate cotransporting polypeptide during pregnancy in the rat. J Hepatol 2003;38:148-55.
27. Ananthanarayanan M, Ng OC, Boyer JL, et al. Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies. Am J Physiol 1994;267:G637-43.
28. Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-50.
29. Trauner M, Arrese, M, Soroka CJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-64.
30. Chomczynski P, Sacchi N. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
31. Rolland V, Le Liepvre X, Houbiguian ML, et al. C/EBP alpha expression in adipose tissue of genetically obese Zucker rats. Biochem Biophys Res Commun 1995;207:761-7.
32. Rolland V, Dugail I, Le Liepvre X, et al. Evidence of increased glyceraldehyde-3-phosphate dehydrogenase and fatty acid synthetase promoter activities in transiently transfected adipocytes from genetically obese rats. J Biol Chem 1995;270:1102-6.
33. Hardikar W, Ananthanarayanan M, Suchy FJ. Differential ontogenic regulation of basolaterol and canalicular bile acid transport proteins in rat liver. J Biol Chem 1995;270:20841-6.
34. Arrese M, Pizarro M, Solis N, et al. Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathway. J Hepatol 1997;26:694-702.
35. Moreno M, Molina H, Amigo L, et al. Overexpression of caveolins increases bile salt secretion in mice. Hepatology 2003;38:1477-88.
36. Geier A, Dietrich CG, Voigt S, et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 2003;38:345-54.
37. Hockings PD, Changani KK, Saeed N, et al. Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Diabetes Obes Metab 2003;5:234-43.
38. Barazzoni R, Zanetti M, Stebel M, et al. Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats. Gastroenterology 2003;124:1188-92.
39. Gabriely I, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002;51:2951-8.
40. Elferink RO. Cholestasis. Gut 2003;52(suppl 2):42-8.
41. Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 2001;34:351-9.
42. Cao J, Stieger B, Meier PJ, et al. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol Gastrointest Liver Physiol 2002;283:G757-66.
43. Bodo A, Bakos E, Szeri F, et al. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol Lett 2003;140:133-43.
44. Ballatori N, Truong AT. Glutathione as a primary osmotic driving force in hepatic bile formation. Am J Physiol 1992;263:G617-24.
45. Ito K, Suzuki H, Hirohashi T, et al. Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J Biol Chem 1998;273:1684-8.
46. Wielandt AM, Vollrath V, Manzano M, et al. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichioropnenoxyacetic acid in the mouse liver. Biochem J 1999;341:105-11.
47. Haussinger D, Schmitt M, Weiergraber O, et al. Short-term regulation of canalicular transport. Semin Liver Dis 2000;20:307-21.
48. Trauner M, Nathanson MH, Rydberg SA, et al. Endotoxin impairs biliary glutathione and HCO3-excretion and blocks the choleretic effect of nitric oxide in rat liver. Hepatology 1997;25:1184-91.
49. Trauner M, Arrese M, Lee H, et al. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 1998;101:2092-100.
50. Lee JM, Trauner M, Soroka CJ, et al. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000;118:163-72.
51. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF-alpha inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003;37:343-50.
52. van Waarde WM, Verkade HJ, Wolters H, et al. Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. Gastroenterology 2002;122:1842-52.